Pier Capital’s Intersect ENT, Inc XENT Stock Holding History

Pier Capital’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-287,250	Closed	-$6.72M	–	143
2015 Q3	$6.72M	Buy	287,250 +40,529	+16%	+$1.12M	1.09%	20
2015 Q2	$7.06M	Sell	246,721 -8,193	-3%	-$215K	1.02%	41
2015 Q1	$6.58M	Buy	+254,914	New	+$5.83M	0.99%	59

Other funds holding XENT

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KIA

Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pier Capital's XENT Position: Q4 2015 in Review

Pier Capital sold out of Intersect ENT, Inc (XENT) in Q4 2015, closing a stake of 287,250 shares — an estimated $6.72M sold.

Pier Capital first reported a position in XENT in Q1 2015 and held it in 3 quarters. The position peaked at $7.06M in Q2 2015. 115 funds tracked by Wall St. Rank hold XENT as of Q4 2015.

Pier Capital reported no remaining Intersect ENT, Inc position as of Q4 2015 after selling out during the quarter.
Pier Capital sold 287,250 Intersect ENT, Inc shares in Q4 2015, an estimated $6.72M.
Pier Capital first reported a position in Intersect ENT, Inc in Q1 2015 and held it in 3 quarters.
Pier Capital's Intersect ENT, Inc position peaked at $7.06M in Q2 2015.
115 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2015.

Based on Pier Capital's 13F filing for Q4 2015, filed 12 Feb 2016.